Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (3038)	5/26/1999 6:04:00 PM
From: Don Miller	Read Replies (1) of 10280

Richard, Pardon my ignorance of the John Hopkins test if they were ocular specific. Is your evaluation of this drug ocular specific, or is it from the broad allergy perspective? If the drug will address things I can not be treated for in any other way, you can be sure I would take a once a month shot or the oral version, if one existed. How expensive is the dosage? The NBC Nightline description was stressing a one shoot per month cycle. Where does the second doc. office visit occur? How long is a observation period after a shoot? Before they gave me the serum,I had to wait in line way too long in the crowded shot nurse outer office to get my twice weekly shoots. As an investor I take no comfort in a portion of the market not wanting to take shoots. Again Richard please pardon my memory, but I believe you are new to this board, so I would like to know a little more. Bottom line: Do you own SEPR? Since you were exposed to the knowledge of this drug have you increased your position in either GNE or Novartis, or managed to buy into Tanox somehow?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next